Bang Viet Bui

Bang Viet Bui

Auto-generated profile, based on publicly available information

Bang Viet Bui

Department of Optometry and Vision Sciences, The University of Melbourne, Parkville, Victoria, Australia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
XHXavier Hadoux
Xavier Hadoux
FHFlora Hui
Flora Hui
JLJeremiah K. H. Lim
Jeremiah K. H. Lim
CMColin L. Masters
Colin L. Masters
APAlice Pébay
Alice Pébay
PWPeter van Wijngaarden
Peter van Wijngaarden
Studies of rodent models of Alzheimer’s disease (AD) and of human tissues suggest that the retinal changes that occur in AD, including the accumulation of amyloid beta (Aβ), may serve as surrogate markers of brain Aβ levels. As Aβ has a wavelength-dependent effect on light scatter, we investigate the potential for in vivo retinal hyperspectral imaging to serve as a biomarker of brain Aβ. Significant differences in the retinal reflectance spectra are found between individuals with high Aβ burden on brain PET imaging and mild cognitive impairment (n = 15), and age-matched PET-negative controls (n = 20). Retinal imaging scores are correlated with brain Aβ loads. The findings are validated in an independent cohort, using a second hyperspectral camera. A similar spectral difference is found between control and 5xFAD transgenic mice that accumulate Aβ in the brain and retina. These findings indicate that retinal hyperspectral imaging may predict brain Aβ load.

15 February 2004 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
BBBang V. Bui
Bang V. Bui
BFBrad Fortune
Brad Fortune
The purpose of this study was to determine what contributions are made to the rat full‐field electroretinogram (ERG) by ganglion cells (GCs). To that end, the ERG was assessed longitudinally following optic nerve transection (ONTx). Additional studies were conducted using intravitreal injections of pharmacologically active substances. The ERG was recorded simultaneously from both eyes of anaesthetized adult Brown‐Norway rats (ketamine: xylazine: acepromazine, 55: 5: 1 mg kg−1) using custom silver chloride electrodes. Stimuli were brief, white xenon discharges delivered via a Ganzfeld under dark‐adapted and light‐adapted conditions (150 cd m−2). ERGs were obtained 1, 2, 3, 4 and 9 weeks after ONTx (n= 8) or sham (n= 8) operations. ONTx reduced both positive and negative components of the scotopic threshold response (pSTR and nSTR). Scotopic ERG responses to brighter flashes, including a‐waves, b‐waves and oscillatory potentials (OPs) were unaffected by ONTx. ONTx reduced the photopic b‐wave and OPs. TTX (6 μm) reduced the pSTR and nSTR, but not the scotopic a‐wave, b‐wave or OPs. TTX had dramatic effects on the photopic ERG, surpassing the effects of ONTx. TTX application 9 weeks post‐ONTx had little additional effect on the STR. Inhibition of inner retinal responses using GABA (10 mm) or NMDA (0.8 mm) reduced the nSTR substantially. Similar results were obtained with antagonists of AMPA/KA ionotropic glutamate receptors 6‐cyano‐7‐nitroquinoxaline‐2,3(1H,4H)‐dione (CNQX, 0.2 mm) or cis‐2,3‐piperidinedicarboxylic acid (PDA, 5 mm); however, both also reduced the scotopic b‐wave by ∼40 %. By contrast, the NMDA receptor antagonist D(‐)‐2‐amino‐7‐phosphonoheptanoic acid (D‐AP7, 0.2 mm) had no effect alone, but the combination of D‐AP7 and CNQX completely abolished the STR. The results of this study indicate that: (1) both pSTR and nSTR components in the rat depend directly upon intact GC responses, and that amacrine cell contributions to these components are relatively small; (2) scotopic ERG response components to brighter flashes receive little influence from GCs; (3) the rat photopic ERG also reflects GC signals and may serve as an additional useful test of GC function; (4) TTX had dramatic effects on the rat photopic ERG that were not attributable to GC currents, but rather to voltage‐gated sodium currents in amacrine or interplexiform cells; (5) a small residual negative STR persisted after ONTx that was likely to be generated by graded responses of third‐order retinal cells, most likely amacrine cells.

17 November 2016 in Frontiers in Neuroscience
Verified
Journal Article
Open access
JLJeremiah K. H. Lim
Jeremiah K. H. Lim
QLQiao-Xin Li
Qiao-Xin Li
ZHZheng He
Zheng He
AVAlgis Jonas Vingrys
Algis Jonas Vingrys
VWVickie Wong
Vickie Wong
Christine NguyenChristine Nguyen
Christine Nguyen
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder resulting in dementia and eventual death. It is the leading cause of dementia and the number of cases are projected to rise in the next few decades. Pathological hallmarks of AD include the presence of hyperphosphorylated tau and amyloid protein deposition. Currently, these pathological biomarkers are detected either through cerebrospinal fluid analysis, brain imaging or post-mortem. Though effective, these methods are not widely available due to issues such as the difficulty in acquiring samples, lack of infrastructure or high cost. Given that the eye possesses clear optics and shares many neural and vascular similarities to the brain, it offers a direct window to cerebral pathology. These unique characteristics lend itself to being a relatively inexpensive biomarker for AD which carries the potential for wide implementation. The development of ocular biomarkers can have far implications in the discovery of treatments which can improve the quality of lives of patients. In this review, we consider the current evidence for ocular biomarkers in AD and explore potential future avenues of research in this area.

1 January 2005 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
BBBang V. Bui
Bang V. Bui
BEBeth Edmunds
Beth Edmunds
GCGeorge A. Cioffi
George A. Cioffi
BFBrad Fortune
Brad Fortune
Purpose. To assess the frequency of shedding of herpes simplex virus type 1 (HSV-1) DNA in tears and saliva of asymptomatic individuals.

1 June 2016 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
SHSandy S. C. Hung
Sandy S. C. Hung
VCVicki Chrysostomou
Vicki Chrysostomou
FLFan Li
Fan Li
JLJeremiah K. H. Lim
Jeremiah K. H. Lim
JWJiang-Hui Wang
Jiang-Hui Wang
AHAlex Hewitt
Alex Hewitt
Purpose: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) has recently been adapted to enable efficient editing of the mammalian genome, opening novel avenues for therapeutic intervention of inherited diseases. In seeking to disrupt yellow fluorescent protein (YFP) in a Thy1-YFP transgenic mouse, we assessed the feasibility of utilizing the adeno-associated virus 2 (AAV2) to deliver CRISPR/Cas for gene modification of retinal cells in vivo. Methods: Single guide RNA (sgRNA) plasmids were designed to target YFP, and after in vitro validation, selected guides were cloned into a dual AAV system. One AAV2 construct was used to deliver Streptococcus pyogenes Cas9 (SpCas9), and the other delivered sgRNA against YFP or LacZ (control) in the presence of mCherry. Five weeks after intravitreal injection, retinal function was determined using electroretinography, and CRISPR/Cas-mediated gene modifications were quantified in retinal flat mounts. Results: Adeno-associated virus 2–mediated in vivo delivery of SpCas9 with sgRNA targeting YFP significantly reduced the number of YFP fluorescent cells of the inner retina of our transgenic mouse model. Overall, we found an 84.0% (95% confidence interval [CI]: 81.8–86.9) reduction of YFP-positive cells in YFP-sgRNA–infected retinal cells compared to eyes treated with LacZ-sgRNA. Electroretinography profiling found no significant alteration in retinal function following AAV2-mediated delivery of CRISPR/Cas components compared to contralateral untreated eyes. Conclusions: Thy1-YFP transgenic mice were used as a rapid quantifiable means to assess the efficacy of CRISPR/Cas-based retinal gene modification in vivo. We demonstrate that genomic modification of cells in the adult retina can be readily achieved by viral-mediated delivery of CRISPR/Cas.

1 June 2004 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
BFBrad Fortune
Brad Fortune
BBBang V. Bui
Bang V. Bui
JMJohn C. Morrison
John C. Morrison
EJElaine C. Johnson
Elaine C. Johnson
JDJin Dong
Jin Dong
GCGeorge A. Cioffi
George A. Cioffi
Purpose. To characterize retinal functional consequences of elevated intraocular pressure (IOP) in a rat model of experimental glaucoma. methods. Unilateral elevation of IOP was produced by hypertonic saline injection into an episcleral vein in 20 adult male Brown-Norway rats. IOP was measured in both eyes of awake animals four to five times per week. After 5 weeks, animals were dark adapted overnight (>12 hours) and full-field electroretinograms (ERGs) were obtained simultaneously from both eyes. Scotopic ERG stimuli were brief white flashes (–6.64–2.72 log cd-s/m2). Photopic responses were also obtained (0.97–2.72 log cd-s/m2) after 15 minutes of light adaptation (150 cd/m2). Eyes were processed the following day for histologic evaluation by light microscopy, including masked determination of optic nerve injury grade (ONIG; 1, normal; 5, severe, diffuse damage). results. Among experimental eyes, the group average IOP (±SD) was 34.5 ± 4.1 mm Hg, whereas the average for control eyes was 28.1 ± 0.5 mm Hg (t = 7.1, P < 0.0001). The average ONIG for experimental and control eye groups, respectively, was 3.4 ± 1.7 and 1.0 ± 0.02 (t = 6.3, P < 0.0001). The ONIG increased with mean IOP in experimental eyes (r 2 = 0.78, P < 0.0001) and was unrelated to mean IOP in control eyes (r 2 = 0.09, P = 0.18). In experimental eyes with relatively mild IOP elevation (mean IOP < 31 mm Hg) and no structural (histologic) damage to the optic nerve evident by light microscopy (ONIG = 1.1 ± 0.2, n = 5), there was a selective reduction of the positive scotopic threshold response (pSTR; P < 0.001), whereas other ERG components remained unaltered. In four of the five eyes, pSTR amplitude was reduced by more than 50%, whereas all five had normal scotopic a-wave, b-wave, and OP amplitudes. Eyes with mean IOP of more than 35 mm Hg had reduced a-wave, b-wave, and oscillatory potential (OP) amplitudes. conclusions. As demonstrated by prior studies, selective loss of the pSTR is indicative of selective retinal ganglion cell (RGC) injury. In this rat model of experimental glaucoma, selective RGC functional injury occurred before the onset of structural damage, as assessed by light microscopy of optic nerve tissue. The highest IOP levels resulted in nonselective functional loss. Thus, in rodent models of experimental glaucoma, lower levels of chronically elevated IOP may be more relevant to human primary chronic glaucoma.